Therefore, in the present study, we aimed to determine the impact of alterations in intestinal microbiota and TLR2 signaling on α-synuclein pathology in nontransgenic mice administered α-synuclein PFFs as a model of PD due to nongenetic causes. The gene discussed is SNCA; the disease is Parkinson disease.